Advanced Flower Capital (AFCG) Q3 2024 earnings summary

Executive summary

• Transitioned to a pure-play cannabis mortgage REIT after spinning off the commercial real estate portfolio on July 9, 2024, now focusing solely on senior secured loans to cannabis operators.

• Surpassed the 2024 origination target, closing $116 million in new loan commitments year-to-date and maintaining an active pipeline of over $400 million.

• Portfolio diversified across 14 cannabis loans in 15 states, with a current commitment of $383 million and modest Florida exposure underwritten to current medical market conditions.

• Management has structured over $15 billion in loan transactions and maintains a BBB+ investment grade rating as of September 2024.

• Well-positioned to deploy capital into strong risk-adjusted return deals amid limited access to capital in the cannabis sector.

Financial highlights

• Q3 2024 distributable earnings were $7.2 million ($0.35 per share), with GAAP net income of $1.4 million ($0.06 per share).

• Book value per share was $9.42 as of September 30, 2024, down from $15.64 at year-end 2023 due to the spin-off.

• Paid a $0.33 per share dividend for Q3 2024, with a policy to pay 85–100% of distributable earnings annually.

• Ended Q3 with $298.7 million in principal outstanding across 13 loans; as of November 1, 2024, $338 million across 14 loans.

• Weighted average portfolio yield-to-maturity was approximately 18%.

Outlook and guidance

• Expects to continue cautious, quality-focused capital deployment in 2025, with a formal origination target to be provided in the next quarter.

• Maintains over $75 million in liquidity and aims to remain fully invested while prioritizing strong credits.

• Plans to raise additional equity and/or debt to support loan origination growth.

• Anticipates favorable conditions for lending due to ongoing capital scarcity in the cannabis sector.

• Management expects continued portfolio diversification and optimization, with a focus on credit quality and risk management.